VanEck Pharmaceutical ETF Rating $91.78 +1.36 (+1.50%) As of 04:00 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock VanEck Pharmaceutical ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PPH Aggregate RatingModerate Buy 2.73Holdings in PPH have an aggregate rating of Moderate Buy based on 272 analyst ratings issued in the past year covering 22 companies (94.0% of the portfolio).PPH Aggregate Price Target$91.78High Prediction$91.78Average Prediction$91.78Low Prediction$91.78Holdings in PPH have an aggregate price target of $91.78 and a range of $91.78 to $91.78 covering 22 companies (94.0% of the portfolio).PPH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy6 Buy rating(s)Moderate Buy9 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by VanEck Pharmaceutical ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 22 PPH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings11.44%LLYEli Lilly and Company$811.62+0.4%4.9254 of 5 stars2.76$1,011.37 24.6%21Trending NewsAnalyst Revision6.41%JNJJohnson & Johnson$156.61+0.9%4.7873 of 5 stars2.55$170.88 9.1%20Trending News6.18%ABBVAbbVie$192.27+0.4%4.7184 of 5 stars2.81$211.29 9.9%27Trending NewsAnalyst ForecastAnalyst Revision5.33%CORCencora$294.96+2.9%4.5113 of 5 stars2.90$306.91 4.1%10Positive News5.21%MCKMcKesson$730.39+1.8%4.3901 of 5 stars2.87$694.38 -4.9%15Positive NewsAnalyst ForecastInsider Trade5.12%HLNHaleon$11.01+0.9%2.8339 of 5 stars2.73$12.33 11.9%11Positive NewsUpcoming Earnings5.06%NVONovo Nordisk A/S$81.07+3.0%4.4783 of 5 stars2.27$112.00 38.2%11Trending NewsGap Up4.99%AZNAstraZeneca$75.00+1.7%2.9365 of 5 stars3.13$85.00 13.3%8Positive News4.96%GSKGSK$42.50+2.1%1.9786 of 5 stars2.27$37.38 -12.1%11Positive News4.91%TEVATeva Pharmaceutical Industries$17.67+2.0%4.1228 of 5 stars3.20$24.44 38.3%104.89%ZTSZoetis$168.64+1.4%4.6001 of 5 stars3.10$212.75 26.2%10Positive News4.71%TAKTakeda Pharmaceutical$15.39+1.5%1.8275 of 5 stars3.001Positive News4.50%SNYSanofi$50.83+2.3%3.4014 of 5 stars3.13$61.50 21.0%8Short Interest ↑4.33%MRKMerck & Co., Inc.$81.74+1.8%4.9971 of 5 stars2.43$109.19 33.6%21Trending NewsAnalyst Revision4.22%PFEPfizer$24.85+1.5%4.9792 of 5 stars2.53$29.17 17.4%15Trending NewsAnalyst Revision3.75%BMYBristol-Myers Squibb$50.68+1.0%4.8566 of 5 stars2.32$58.00 14.4%22Trending NewsAnalyst Revision2.33%VTRSViatris$9.09+1.2%2.5476 of 5 stars1.80$10.40 14.4%51.74%JAZZJazz Pharmaceuticals$110.29-0.2%4.9678 of 5 stars2.92$184.00 66.8%13Analyst Forecast1.38%ELANElanco Animal Health$14.19-0.6%1.0644 of 5 stars2.43$15.17 6.9%7Positive News1.09%AXSMAxsome Therapeutics$106.25-1.7%4.7031 of 5 stars3.06$172.33 62.2%16Trending NewsAnalyst ForecastInsider TradeAnalyst Revision0.86%PRGOPerrigo$27.22-0.5%4.6209 of 5 stars2.25$33.00 21.2%4Positive News0.59%OGNOrganon & Co.$10.07-0.1%4.7957 of 5 stars2.50$18.00 78.7%6Trending News This page (NASDAQ:PPH) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Pharmaceutical ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Pharmaceutical ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
